VolitionRX Ltd (VNRX):企業の製品パイプライン分析2018

◆英語タイトル:VolitionRX Ltd (VNRX) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C3009
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:69
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and development, and offers clinical trial services. The company has collaboration with hospital, medical center, universities and research institute. It operates in Belgium, Singapore, the UK and the US. VolitionRX is headquartered in Singapore City, Singapore.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company VolitionRX Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
VolitionRX Ltd Company Overview 6
VolitionRX Ltd Company Snapshot 6
VolitionRX Ltd Pipeline Products and Ongoing Clinical Trials Overview 6
VolitionRX Ltd – Pipeline Analysis Overview 8
VolitionRX Ltd – Key Facts 8
VolitionRX Ltd – Major Products and Services 9
VolitionRX Ltd Pipeline Products by Development Stage 10
VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14
VolitionRX Ltd Pipeline Products Overview 16
HyperGenomics Diagnostic Test – Colon Cancer 16
HyperGenomics Diagnostic Test – Colon Cancer Product Overview 16
HyperGenomics Diagnostic Test – Leukaemia 17
HyperGenomics Diagnostic Test – Leukaemia Product Overview 17
HyperGenomics Diagnostic Test – Prostate Cancer 18
HyperGenomics Diagnostic Test – Prostate Cancer Product Overview 18
Nu.Q CRC Screening Test 19
Nu.Q CRC Screening Test Product Overview 19
Nu.Q CRC Screening Test Clinical Trial 20
Nu.Q CRC Symptomatic Test 21
Nu.Q CRC Symptomatic Test Product Overview 21
Nu.Q CRC Triage Test 22
Nu.Q CRC Triage Test Product Overview 22
Nu.Q Frontline Asymptomatic CRC Screening Test 23
Nu.Q Frontline Asymptomatic CRC Screening Test Product Overview 23
Nu.Q Frontline Asymptomatic CRC Screening Test Clinical Trial 24
NuQ – A Androgen Receptor Cell Culture ELISA Kit 25
NuQ – A Androgen Receptor Cell Culture ELISA Kit Product Overview 25
NuQ – A EZH2 Cell Culture ELISA Kit 26
NuQ – A EZH2 Cell Culture ELISA Kit Product Overview 26
NuQ – A HMGB1 Cell Culture ELISA Kit 27
NuQ – A HMGB1 Cell Culture ELISA Kit Product Overview 27
NuQ – A Oestrogen Receptor Cell Culture ELISA Kit 28
NuQ – A Oestrogen Receptor Cell Culture ELISA Kit Product Overview 28
NuQ – A Progesterone Receptor Cell Culture ELISA Kit 29
NuQ – A Progesterone Receptor Cell Culture ELISA Kit Product Overview 29
NuQ – Prostate Cancer 30
NuQ – Prostate Cancer Product Overview 30
NuQ – Prostate Cancer Clinical Trial 31
NuQ – T001 Total Nucleosome ELISA Kit 32
NuQ – T001 Total Nucleosome ELISA Kit Product Overview 32
NuQ Diagnostic Test – Lung Cancer 33
NuQ Diagnostic Test – Lung Cancer Product Overview 33
NuQ Diagnostic Test – Lung Cancer Clinical Trial 34
NuQ Diagnostic Test – Pancreatic Cancer 35
NuQ Diagnostic Test – Pancreatic Cancer Product Overview 35
NuQ Diagnostic Test – Pancreatic Cancer Clinical Trial 36
NuQ Endo 37
NuQ Endo Product Overview 37
NuQ Endo Clinical Trial 38
NuQ T003 Assay – Colorectal Cancer 39
NuQ T003 Assay – Colorectal Cancer Product Overview 39
NuQ V001 Assay – Colorectal Cancer 40
NuQ V001 Assay – Colorectal Cancer Product Overview 40
NuQ X001S Assay – Colorectal Cancer 41
NuQ X001S Assay – Colorectal Cancer Product Overview 41
NuQ X001S Assay – Colorectal Cancer Clinical Trial 42
NuQ-B 43
NuQ-B Product Overview 43
NuQ-IHC 44
NuQ-IHC Product Overview 44
NuQ-M Gamma – H2AX Cell Culture ELISA Kit 45
NuQ-M Gamma – H2AX Cell Culture ELISA Kit Product Overview 45
NuQ-M H3K27(Me)3 Cell Culture ELISA Kit 46
NuQ-M H3K27(Me)3 Cell Culture ELISA Kit Product Overview 46
NuQ-M H4K16(Ac) Cell Culture ELISA Kit 47
NuQ-M H4K16(Ac) Cell Culture ELISA Kit Product Overview 47
NuQ-M H4K20(Me)3 Cell Culture ELISA Kit 48
NuQ-M H4K20(Me)3 Cell Culture ELISA Kit Product Overview 48
NuQ-M H4Pan(Ac) Cell Culture ELISA Kit 49
NuQ-M H4Pan(Ac) Cell Culture ELISA Kit Product Overview 49
NuQ-M Ubiquityl H2A Cell Culture ELISA Kit 50
NuQ-M Ubiquityl H2A Cell Culture ELISA Kit Product Overview 50
NuQ-V 51
NuQ-V Product Overview 51
NuQ-V mH2A1.1 Cell Culture ELISA Kit 52
NuQ-V mH2A1.1 Cell Culture ELISA Kit Product Overview 52
NuQ-V mH2A2 Cell Culture ELISA Kit 53
NuQ-V mH2A2 Cell Culture ELISA Kit Product Overview 53
NuQ-X Hydroxymethylated DNA Cell Culture Kit 54
NuQ-X Hydroxymethylated DNA Cell Culture Kit Product Overview 54
NuQ-X Methylated DNA Cell Culture Kit 55
NuQ-X Methylated DNA Cell Culture Kit Product Overview 55
VolitionRX Ltd – Key Competitors 56
VolitionRX Ltd – Key Employees 57
VolitionRX Ltd – Locations And Subsidiaries 58
Head Office 58
Other Locations & Subsidiaries 58
Recent Developments 59
VolitionRX Ltd, Recent Developments 59
Jul 10, 2018: Volition expands clinical development of Nu.Q to Asia Pacific 59
May 10, 2018: VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update 59
May 09, 2018: VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits 60
Mar 07, 2018: VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board 60
Mar 01, 2018: VolitionRX Announces Full Fiscal Year 2017 Financial Results and Business Update 61
Feb 26, 2018: VolitionRx Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer 62
Feb 05, 2018: VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark 63
Jan 03, 2018: VolitionRx Releases Letter to Shareholders Including Status Update on Key Clinical Milestone 63
Nov 09, 2017: VolitionRx Announces Third Quarter 2017 Financial Results and Business Update 64
Sep 22, 2017: VolitionRx Announces the Initial Sale of its New Nu.Q Research Kits 65
Appendix 66
Methodology 66
About GlobalData 69
Contact Us 69
Disclaimer 69

List of Tables
VolitionRX Ltd Pipeline Products and Ongoing Clinical Trials Overview 6
VolitionRX Ltd Pipeline Products by Equipment Type 7
VolitionRX Ltd Pipeline Products by Indication 7
VolitionRX Ltd Ongoing Clinical Trials by Trial Status 7
VolitionRX Ltd, Key Facts 8
VolitionRX Ltd, Major Products and Services 9
VolitionRX Ltd Number of Pipeline Products by Development Stage 10
VolitionRX Ltd Pipeline Products Summary by Development Stage 11
VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14
VolitionRX Ltd Ongoing Clinical Trials Summary 15
HyperGenomics Diagnostic Test - Colon Cancer - Product Status 16
HyperGenomics Diagnostic Test - Colon Cancer - Product Description 16
HyperGenomics Diagnostic Test - Leukaemia - Product Status 17
HyperGenomics Diagnostic Test - Leukaemia - Product Description 17
HyperGenomics Diagnostic Test - Prostate Cancer - Product Status 18
HyperGenomics Diagnostic Test - Prostate Cancer - Product Description 18
Nu.Q CRC Screening Test - Product Status 19
Nu.Q CRC Screening Test - Product Description 19
Nu.Q CRC Screening Test - A Large Multi-center US Clinical Study of Nu.Q Assay in the Screening of Colorectal Cancer 20
Nu.Q CRC Screening Test - Prospective Clinical Study Nu.Q Assay for the Detection of Colorectal Cancer 20
Nu.Q CRC Symptomatic Test - Product Status 21
Nu.Q CRC Symptomatic Test - Product Description 21
Nu.Q CRC Triage Test - Product Status 22
Nu.Q CRC Triage Test - Product Description 22
Nu.Q Frontline Asymptomatic CRC Screening Test - Product Status 23
Nu.Q Frontline Asymptomatic CRC Screening Test - Product Description 23
Nu.Q Frontline Asymptomatic CRC Screening Test - Asymptomatic Colorectal Cancer (CRC) Frontline Screening Study 24
NuQ - A Androgen Receptor Cell Culture ELISA Kit - Product Status 25
NuQ - A Androgen Receptor Cell Culture ELISA Kit - Product Description 25
NuQ - A EZH2 Cell Culture ELISA Kit - Product Status 26
NuQ - A EZH2 Cell Culture ELISA Kit - Product Description 26
NuQ - A HMGB1 Cell Culture ELISA Kit - Product Status 27
NuQ - A HMGB1 Cell Culture ELISA Kit - Product Description 27
NuQ - A Oestrogen Receptor Cell Culture ELISA Kit - Product Status 28
NuQ - A Oestrogen Receptor Cell Culture ELISA Kit - Product Description 28
NuQ - A Progesterone Receptor Cell Culture ELISA Kit - Product Status 29
NuQ - A Progesterone Receptor Cell Culture ELISA Kit - Product Description 29
NuQ - Prostate Cancer - Product Status 30
NuQ - Prostate Cancer - Product Description 30
NuQ - Prostate Cancer - A Retrospective Study to Establish the Efficacy of VolitionRx's NuQ Test to Distinguish Anaplastic Prostate Cancer 31
NuQ - Prostate Cancer - Evaluate the Accuracy of Nu.Q Assay in Diagnosis of Aggressive Prostate Cancer 31
NuQ - Prostate Cancer - Multicenter study to evaluate ability of NuQ to detect prostate cancer 31
NuQ - T001 Total Nucleosome ELISA Kit - Product Status 32
NuQ - T001 Total Nucleosome ELISA Kit - Product Description 32
NuQ Diagnostic Test - Lung Cancer - Product Status 33
NuQ Diagnostic Test - Lung Cancer - Product Description 33
NuQ Diagnostic Test - Lung Cancer - Detection of Lung Cancer with NuQ Blood Test 34
NuQ Diagnostic Test - Lung Cancer - Study to evaluate NuQ for early detection of 27 most prevalent cancers; and to evaluate differences in nucleosome structures between cancers 34
NuQ Diagnostic Test - Pancreatic Cancer - Product Status 35
NuQ Diagnostic Test - Pancreatic Cancer - Product Description 35
NuQ Diagnostic Test - Pancreatic Cancer - Clinical Trial with German Cancer Research Center (DKFZ) to Evaluate NuQ Blood Test for Pancreatic Cancer 36
NuQ Endo - Product Status 37
NuQ Endo - Product Description 37
NuQ Endo - Study to Evaluate the Efficacy of Nu.Q Platform Technology in Diagnosis of Endometriosis 38
NuQ T003 Assay - Colorectal Cancer - Product Status 39
NuQ T003 Assay - Colorectal Cancer - Product Description 39
NuQ V001 Assay - Colorectal Cancer - Product Status 40
NuQ V001 Assay - Colorectal Cancer - Product Description 40
NuQ X001S Assay - Colorectal Cancer - Product Status 41
NuQ X001S Assay - Colorectal Cancer - Product Description 41
NuQ X001S Assay - Colorectal Cancer - Evaluate the Accuracy of NuQ Assays as an Initial Screening Tool for Detecting Colorectal Cancer: A Retrospective Study 42
NuQ-B - Product Status 43
NuQ-B - Product Description 43
NuQ-IHC - Product Status 44
NuQ-IHC - Product Description 44
NuQ-M Gamma - H2AX Cell Culture ELISA Kit - Product Status 45
NuQ-M Gamma - H2AX Cell Culture ELISA Kit - Product Description 45
NuQ-M H3K27(Me)3 Cell Culture ELISA Kit - Product Status 46
NuQ-M H3K27(Me)3 Cell Culture ELISA Kit - Product Description 46
NuQ-M H4K16(Ac) Cell Culture ELISA Kit - Product Status 47
NuQ-M H4K16(Ac) Cell Culture ELISA Kit - Product Description 47
NuQ-M H4K20(Me)3 Cell Culture ELISA Kit - Product Status 48
NuQ-M H4K20(Me)3 Cell Culture ELISA Kit - Product Description 48
NuQ-M H4Pan(Ac) Cell Culture ELISA Kit - Product Status 49
NuQ-M H4Pan(Ac) Cell Culture ELISA Kit - Product Description 49
NuQ-M Ubiquityl H2A Cell Culture ELISA Kit - Product Status 50
NuQ-M Ubiquityl H2A Cell Culture ELISA Kit - Product Description 50
NuQ-V - Product Status 51
NuQ-V - Product Description 51
NuQ-V mH2A1.1 Cell Culture ELISA Kit - Product Status 52
NuQ-V mH2A1.1 Cell Culture ELISA Kit - Product Description 52
NuQ-V mH2A2 Cell Culture ELISA Kit - Product Status 53
NuQ-V mH2A2 Cell Culture ELISA Kit - Product Description 53
NuQ-X Hydroxymethylated DNA Cell Culture Kit - Product Status 54
NuQ-X Hydroxymethylated DNA Cell Culture Kit - Product Description 54
NuQ-X Methylated DNA Cell Culture Kit - Product Status 55
NuQ-X Methylated DNA Cell Culture Kit - Product Description 55
VolitionRX Ltd, Key Employees 57
VolitionRX Ltd, Subsidiaries 58
Glossary 68

List of Figures
VolitionRX Ltd Pipeline Products by Equipment Type 7
VolitionRX Ltd Pipeline Products by Development Stage 10
VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14

★海外企業調査レポート[VolitionRX Ltd (VNRX):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pentagon Federal Credit Union:企業の戦略的SWOT分析
    Pentagon Federal Credit Union - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Electromagnetic Geoservices ASA (EMGS):石油・ガス:M&Aディール及び事業提携情報
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …
  • SurModics Inc (SRDX)-医療機器分野:企業M&A・提携分析
    Summary SurModics Inc (SurModics) is a provider of device drug delivery coating and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes medical device coating technologies and surface modification coating technologies. Its technologies are employed …
  • The Hut Group Ltd:企業のM&A・事業提携・投資動向
    The Hut Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Hut Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Laissez-Faire Catering Pty Ltd:企業の戦略・SWOT・財務分析
    Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Diebold Nixdorf, Incorporated:戦略・SWOT・企業財務分析
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Mckesson Europe AG (CLS1):企業の財務・戦略的SWOT分析
    Mckesson Europe AG (CLS1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ATLAS Oil Company:石油・ガス:M&Aディール及び事業提携情報
    Summary ATLAS Oil Company (ATLAS) is an oil and gas company that offers fuel supply and logistic services. The company’s services comprise supply, renewable fuels, bulk fueling, fuel on demand, logistics, fixed price contracts, frac site fueling, emergency refuel, crude hauling, transloading and on- …
  • University of Pennsylvania-製薬・医療分野:企業M&A・提携分析
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • SeQuent Scientific Ltd (SEQUENT):製薬・医療:M&Aディール及び事業提携情報
    Summary SeQuent Scientific Ltd (SeQuent) is a pharmaceutical company that develops and manufactures animal health API, life science and industrial products. The company offers products such as aciclovir sodium, albendazole, artemether, artesunate, amyl meta cresol, citicoline sodium and dihydroartem …
  • Mitsubishi Motors Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Canon Medical Systems Corp:企業の戦略的SWOT分析
    Canon Medical Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hydro-Quebec:企業の戦略的SWOT分析
    Hydro-Quebec - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Acorda Therapeutics, Inc.:企業の戦略・SWOT・財務分析
    Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • E-L Financial Corporation Limited:企業の戦略・SWOT・財務情報
    E-L Financial Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary E-L Financial Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Magnora ASA (SEVAN):企業の財務・戦略的SWOT分析
    Summary Magnora ASA (Magnora) is an oil and gas company that offers engineering, design, and project execution of floating units for offshore applications. The company's floating production units include Hummingbird spirit, Voyageur spirit, Piranema spirit, Goliat FPSO and Western Isles FPSO, among …
  • CJ Corp (001040):企業の財務・戦略的SWOT分析
    CJ Corp (001040) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Golden Agri-Resources Ltd:戦略・SWOT・企業財務分析
    Golden Agri-Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Golden Agri-Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • QR Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary QR Pharma Inc (QR Pharma) is a pharmaceutical company that develops novel drugs for the treatment of alzheimer’s disease, parkinson’s disease and neurodegenerative disorders. The company’s product candidate includes posiphen, which inhibits the translation of amyloid precursor protein. Its P …
  • Eppendorf AG-医療機器分野:企業M&A・提携分析
    Summary Eppendorf AG (Eppendorf) is a life science company. The company develops and produces equipment and services for use in laboratory applications such as liquid handling, cell handling, and sample handling. Its product portfolio includes automated pipetting systems, centrifuges, dispensers, mi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆